ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oral Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-12H12226
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Oral Vaccines Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
BUY CHAPTERS

Global Oral Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-12H12226
Report
June 2025
Pages:146
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

Oral Vaccines Market Size

In 2024, the global market size of Oral Vaccines was estimated to be worth US$ 2690 million and is forecast to reach approximately US$ 3597 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.

Oral Vaccines Market

Oral Vaccines Market

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%.
Middle East and Africa is the largest consumption place, with a consumption market share nearly 54%. Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Vaccines.
The Oral Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Oral Vaccines Market Report

Report Metric Details
Report Name Oral Vaccines Market
CAGR 4.3%
Segment by Type
  • Rotavirus Vaccine
  • Cholera Vaccine
  • Oral Polio Vaccine
Segment by Application
  • Public
  • Private
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, Tiantan Biological, EuBiologics, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Oral Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Vaccines sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Oral Vaccines Market share by region?

Ans: Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%.

What is the Merck, GSK, Sanofi share in Oral Vaccines Market?

Ans: Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares.

Who are the main players in the Oral Vaccines Market report?

Ans: The main players in the Oral Vaccines Market are Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, Tiantan Biological, EuBiologics, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals

What are the Application segmentation covered in the Oral Vaccines Market report?

Ans: The Applications covered in the Oral Vaccines Market report are Public, Private

What are the Type segmentation covered in the Oral Vaccines Market report?

Ans: The Types covered in the Oral Vaccines Market report are Rotavirus Vaccine, Cholera Vaccine, Oral Polio Vaccine

1 Study Coverage
1.1 Oral Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Oral Vaccines Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Rotavirus Vaccine
1.2.3 Cholera Vaccine
1.2.4 Oral Polio Vaccine
1.3 Market by Application
1.3.1 Global Oral Vaccines Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Public
1.3.3 Private
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oral Vaccines Market Size Estimates and Forecasts
2.1.1 Global Oral Vaccines Revenue 2020-2031
2.1.2 Global Oral Vaccines Sales 2020-2031
2.2 Oral Vaccines Market Size by Region: 2024 Versus 2031
2.3 Oral Vaccines Sales by Region (2020-2031)
2.3.1 Global Oral Vaccines Sales by Region: 2020-2025
2.3.2 Global Oral Vaccines Sales Forecast by Region (2026-2031)
2.3.3 Global Oral Vaccines Sales Market Share by Region (2020-2031)
2.4 Oral Vaccines Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Oral Vaccines Revenue by Region: 2020-2025
2.4.2 Global Oral Vaccines Revenue Forecast by Region (2026-2031)
2.4.3 Global Oral Vaccines Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Oral Vaccines Sales by Type (2020-2031)
3.1.1.1 Global Oral Vaccines Sales Volume by Type (2020-2031)
3.1.1.2 Global Oral Vaccines Sales Market Share by Type (2020-2031)
3.1.2 Global Oral Vaccines Revenue by Type (2020-2031)
3.1.2.1 Global Oral Vaccines Revenue by Type (2020-2031)
3.1.2.2 Global Oral Vaccines Revenue Market Share by Type (2020-2031)
3.1.3 Oral Vaccines Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Oral Vaccines Sales by Application (2020-2031)
3.2.1.1 Global Oral Vaccines Sales Volume by Application (2020-2031)
3.2.1.2 Global Oral Vaccines Sales Market Share by Application (2020-2031)
3.2.2 Global Oral Vaccines Revenue by Application (2020-2031)
3.2.2.1 Global Oral Vaccines Revenue by Application (2020-2031)
3.2.2.2 Global Oral Vaccines Revenue Market Share by Application (2020-2031)
3.2.3 Oral Vaccines Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Rotavirus Vaccine of Oral Vaccines Revenue Market Share by Application
3.3.2 Cholera Vaccine of Oral Vaccines Revenue Market Share by Application
3.3.3 Oral Polio Vaccine of Oral Vaccines Revenue Market Share by Application
4 Global Oral Vaccines by Manufacturers
4.1 Global Top Oral Vaccines Manufacturers by Sales (2020-2025)
4.1.1 Global Oral Vaccines Sales by Manufacturer (2020-2025)
4.1.2 Global Oral Vaccines Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Oral Vaccines Manufacturers by Revenue (2020-2025)
4.2.1 Global Oral Vaccines Revenue by Manufacturer (2020-2025)
4.2.2 Global Oral Vaccines Revenue Share by Manufacturer (2020-2025)
4.3 Global Oral Vaccines Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Oral Vaccines Manufacturers Covered: Ranking by Revenue
4.4.2 Global Oral Vaccines Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Oral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Oral Vaccines Manufacturing Base Distribution, Product Type
4.5.1 Oral Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Oral Vaccines Market
4.5.3 Manufacturers Oral Vaccines Product Type and Application
4.5.4 Rotavirus Vaccine Market Sales of Oral Vaccines by Manufacturer
4.5.5 Cholera Vaccine Market Sales of Oral Vaccines by Manufacturer
4.5.6 Oral Polio Vaccine Market Sales of Oral Vaccines by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Merck
5.1.1 Merck Company Information
5.1.2 Merck Description, Business Overview
5.1.3 Merck Oral Vaccines Products Offered
5.1.4 Merck Oral Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Merck Oral Vaccines Sales by Product in 2024
5.1.6 Merck Oral Vaccines Sales by Application in 2024
5.1.7 Merck Oral Vaccines Sales by Geographic Area in 2024
5.1.8 Merck Recent Developments
5.2 GSK
5.2.1 GSK Company Information
5.2.2 GSK Description, Business Overview
5.2.3 GSK Oral Vaccines Products Offered
5.2.4 GSK Oral Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.2.5 GSK Oral Vaccines Sales by Product in 2024
5.2.6 GSK Oral Vaccines Sales by Application in 2024
5.2.7 GSK Oral Vaccines Sales by Geographic Area in 2024
5.2.8 GSK Recent Developments
5.3 Sanofi
5.3.1 Sanofi Company Information
5.3.2 Sanofi Description, Business Overview
5.3.3 Sanofi Oral Vaccines Products Offered
5.3.4 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Sanofi Oral Vaccines Sales by Product in 2024
5.3.6 Sanofi Oral Vaccines Sales by Application in 2024
5.3.7 Sanofi Oral Vaccines Sales by Geographic Area in 2024
5.3.8 Sanofi Recent Developments
5.4 Lanzhou Institute
5.4.1 Lanzhou Institute Company Information
5.4.2 Lanzhou Institute Description, Business Overview
5.4.3 Lanzhou Institute Oral Vaccines Products Offered
5.4.4 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Lanzhou Institute Oral Vaccines Sales by Product in 2024
5.4.6 Lanzhou Institute Oral Vaccines Sales by Application in 2024
5.4.7 Lanzhou Institute Oral Vaccines Sales by Geographic Area in 2024
5.4.8 Lanzhou Institute Recent Developments
5.5 Serum Institute
5.5.1 Serum Institute Company Information
5.5.2 Serum Institute Description, Business Overview
5.5.3 Serum Institute Oral Vaccines Products Offered
5.5.4 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Serum Institute Oral Vaccines Sales by Product in 2024
5.5.6 Serum Institute Oral Vaccines Sales by Application in 2024
5.5.7 Serum Institute Oral Vaccines Sales by Geographic Area in 2024
5.5.8 Serum Institute Recent Developments
5.6 Valneva
5.6.1 Valneva Company Information
5.6.2 Valneva Description, Business Overview
5.6.3 Valneva Oral Vaccines Products Offered
5.6.4 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Valneva Oral Vaccines Sales by Product in 2024
5.6.6 Valneva Oral Vaccines Sales by Application in 2024
5.6.7 Valneva Oral Vaccines Sales by Geographic Area in 2024
5.6.8 Valneva Recent Developments
5.7 Shanghai United Cell
5.7.1 Shanghai United Cell Company Information
5.7.2 Shanghai United Cell Description, Business Overview
5.7.3 Shanghai United Cell Oral Vaccines Products Offered
5.7.4 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Shanghai United Cell Oral Vaccines Sales by Product in 2024
5.7.6 Shanghai United Cell Oral Vaccines Sales by Application in 2024
5.7.7 Shanghai United Cell Oral Vaccines Sales by Geographic Area in 2024
5.7.8 Shanghai United Cell Recent Developments
5.8 Bibcol
5.8.1 Bibcol Company Information
5.8.2 Bibcol Description, Business Overview
5.8.3 Bibcol Oral Vaccines Products Offered
5.8.4 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Bibcol Oral Vaccines Sales by Product in 2024
5.8.6 Bibcol Oral Vaccines Sales by Application in 2024
5.8.7 Bibcol Oral Vaccines Sales by Geographic Area in 2024
5.8.8 Bibcol Recent Developments
5.9 PaxVax
5.9.1 PaxVax Company Information
5.9.2 PaxVax Description, Business Overview
5.9.3 PaxVax Oral Vaccines Products Offered
5.9.4 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.9.5 PaxVax Oral Vaccines Sales by Product in 2024
5.9.6 PaxVax Oral Vaccines Sales by Application in 2024
5.9.7 PaxVax Oral Vaccines Sales by Geographic Area in 2024
5.9.8 PaxVax Recent Developments
5.10 Vabiotech
5.10.1 Vabiotech Company Information
5.10.2 Vabiotech Description, Business Overview
5.10.3 Vabiotech Oral Vaccines Products Offered
5.10.4 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Vabiotech Oral Vaccines Sales by Product in 2024
5.10.6 Vabiotech Oral Vaccines Sales by Application in 2024
5.10.7 Vabiotech Oral Vaccines Sales by Geographic Area in 2024
5.10.8 Vabiotech Recent Developments
5.11 Tiantan Biological
5.11.1 Tiantan Biological Company Information
5.11.2 Tiantan Biological Description, Business Overview
5.11.3 Tiantan Biological Oral Vaccines Products Offered
5.11.4 Tiantan Biological Oral Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Tiantan Biological Oral Vaccines Sales by Product in 2024
5.11.6 Tiantan Biological Oral Vaccines Sales by Application in 2024
5.11.7 Tiantan Biological Oral Vaccines Sales by Geographic Area in 2024
5.11.8 Tiantan Biological Recent Developments
5.12 EuBiologics
5.12.1 EuBiologics Company Information
5.12.2 EuBiologics Description, Business Overview
5.12.3 EuBiologics Oral Vaccines Products Offered
5.12.4 EuBiologics Oral Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.12.5 EuBiologics Oral Vaccines Sales by Product in 2024
5.12.6 EuBiologics Oral Vaccines Sales by Application in 2024
5.12.7 EuBiologics Oral Vaccines Sales by Geographic Area in 2024
5.12.8 EuBiologics Recent Developments
5.13 Panacea Biotec Ltd
5.13.1 Panacea Biotec Ltd Company Information
5.13.2 Panacea Biotec Ltd Description, Business Overview
5.13.3 Panacea Biotec Ltd Oral Vaccines Products Offered
5.13.4 Panacea Biotec Ltd Oral Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Panacea Biotec Ltd Oral Vaccines Sales by Product in 2024
5.13.6 Panacea Biotec Ltd Oral Vaccines Sales by Application in 2024
5.13.7 Panacea Biotec Ltd Oral Vaccines Sales by Geographic Area in 2024
5.13.8 Panacea Biotec Ltd Recent Developments
5.14 Bio-Med
5.14.1 Bio-Med Company Information
5.14.2 Bio-Med Description, Business Overview
5.14.3 Bio-Med Oral Vaccines Products Offered
5.14.4 Bio-Med Oral Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Bio-Med Oral Vaccines Sales by Product in 2024
5.14.6 Bio-Med Oral Vaccines Sales by Application in 2024
5.14.7 Bio-Med Oral Vaccines Sales by Geographic Area in 2024
5.14.8 Bio-Med Recent Developments
5.15 Halfkin Bio-Pharmaceuticals
5.15.1 Halfkin Bio-Pharmaceuticals Company Information
5.15.2 Halfkin Bio-Pharmaceuticals Description, Business Overview
5.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Products Offered
5.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.15.5 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales by Product in 2024
5.15.6 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales by Application in 2024
5.15.7 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales by Geographic Area in 2024
5.15.8 Halfkin Bio-Pharmaceuticals Recent Developments
6 North America
6.1 North America Oral Vaccines Market Size YoY Growth 2020-2031
6.2 North America Oral Vaccines Market Facts & Figures by Country
6.2.1 North America Oral Vaccines Sales by Country (2020-2031)
6.2.2 North America Oral Vaccines Revenue by Country (2020-2031)
6.3 North America Oral Vaccines Sales by Type (2020-2025)
6.4 North America Oral Vaccines Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Oral Vaccines Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Oral Vaccines Market Facts & Figures by Region
7.2.1 Asia-Pacific Oral Vaccines Sales by Region (2020-2031)
7.2.2 Asia-Pacific Oral Vaccines Revenue by Region (2020-2031)
7.3 Asia-Pacific Oral Vaccines Sales by Type (2020-2025)
7.4 Asia-Pacific Oral Vaccines Sales by Application (2020-2025)
8 Europe
8.1 Europe Oral Vaccines Market Size YoY Growth 2020-2031
8.2 Europe Oral Vaccines Market Facts & Figures by Country
8.2.1 Europe Oral Vaccines Sales by Country (2020-2031)
8.2.2 Europe Oral Vaccines Revenue by Country (2020-2031)
8.3 Europe Oral Vaccines Sales by Type (2020-2025)
8.4 Europe Oral Vaccines Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Oral Vaccines Market Size YoY Growth 2020-2031
9.2 Latin America Oral Vaccines Market Facts & Figures by Country
9.2.1 Latin America Oral Vaccines Sales by Country (2020-2031)
9.2.2 Latin America Oral Vaccines Revenue by Country (2020-2031)
9.3 Latin America Oral Vaccines Sales by Type (2020-2025)
9.4 Latin America Oral Vaccines Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Oral Vaccines Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Oral Vaccines Market Facts & Figures by Country
10.2.1 Middle East and Africa Oral Vaccines Sales by Country (2020-2031)
10.2.2 Middle East and Africa Oral Vaccines Revenue by Country (2020-2031)
10.3 Middle East and Africa Oral Vaccines Sales by Type (2020-2025)
10.4 Middle East and Africa Oral Vaccines Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Oral Vaccines Supply Chain Analysis
11.2 Oral Vaccines Key Raw Materials and Upstream Suppliers
11.3 Oral Vaccines Clients Analysis
11.4 Oral Vaccines Sales Channel and Sales Model Analysis
11.4.1 Oral Vaccines Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Oral Vaccines Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Oral Vaccines Distributors
12 Oral Vaccines Market Dynamics
12.1 Oral Vaccines Industry Trends
12.2 Oral Vaccines Market Drivers
12.3 Oral Vaccines Market Challenges
12.4 Oral Vaccines Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
List of Tables
 Table 1. Global Oral Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Oral Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Oral Vaccines Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Oral Vaccines Sales by Region (2020-2025) & (K Units)
 Table 5. Global Oral Vaccines Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global Oral Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Oral Vaccines Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Oral Vaccines Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global Oral Vaccines Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global Oral Vaccines Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Oral Vaccines Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Oral Vaccines Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global Oral Vaccines Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global Oral Vaccines Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Oral Vaccines Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Oral Vaccines Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global Oral Vaccines Sales Share by Manufacturer (2020-2025)
 Table 18. Oral Vaccines Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Oral Vaccines Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Oral Vaccines Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top Oral Vaccines Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Oral Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Oral Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Vaccines as of 2024)
 Table 24. Oral Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Oral Vaccines Market
 Table 26. Manufacturers Oral Vaccines Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Merck Company Information
 Table 29. Merck Description and Business Overview
 Table 30. Merck Oral Vaccines Product
 Table 31. Merck Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. Merck Sales Proportion of Oral Vaccines by Product in 2024
 Table 33. Merck Sales Proportion of Oral Vaccines by Application in 2024
 Table 34. Merck Sales Proportion of Oral Vaccines by Geographic Area in 2024
 Table 35. Merck Recent Developments
 Table 36. GSK Company Information
 Table 37. GSK Description and Business Overview
 Table 38. GSK Oral Vaccines Product
 Table 39. GSK Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. GSK Sales Proportion of Oral Vaccines by Product in 2024
 Table 41. GSK Sales Proportion of Oral Vaccines by Application in 2024
 Table 42. GSK Sales Proportion of Oral Vaccines by Geographic Area in 2024
 Table 43. GSK Recent Developments
 Table 44. Sanofi Company Information
 Table 45. Sanofi Description and Business Overview
 Table 46. Sanofi Oral Vaccines Product
 Table 47. Sanofi Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. Sanofi Sales Proportion of Oral Vaccines by Product in 2024
 Table 49. Sanofi Sales Proportion of Oral Vaccines by Application in 2024
 Table 50. Sanofi Sales Proportion of Oral Vaccines by Geographic Area in 2024
 Table 51. Sanofi Recent Developments
 Table 52. Lanzhou Institute Company Information
 Table 53. Lanzhou Institute Description and Business Overview
 Table 54. Lanzhou Institute Oral Vaccines Product
 Table 55. Lanzhou Institute Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. Lanzhou Institute Sales Proportion of Oral Vaccines by Product in 2024
 Table 57. Lanzhou Institute Sales Proportion of Oral Vaccines by Application in 2024
 Table 58. Lanzhou Institute Sales Proportion of Oral Vaccines by Geographic Area in 2024
 Table 59. Lanzhou Institute Recent Developments
 Table 60. Serum Institute Company Information
 Table 61. Serum Institute Description and Business Overview
 Table 62. Serum Institute Oral Vaccines Product
 Table 63. Serum Institute Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Serum Institute Sales Proportion of Oral Vaccines by Product in 2024
 Table 65. Serum Institute Sales Proportion of Oral Vaccines by Application in 2024
 Table 66. Serum Institute Sales Proportion of Oral Vaccines by Geographic Area in 2024
 Table 67. Serum Institute Recent Developments
 Table 68. Valneva Company Information
 Table 69. Valneva Description and Business Overview
 Table 70. Valneva Oral Vaccines Product
 Table 71. Valneva Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 72. Valneva Sales Proportion of Oral Vaccines by Product in 2024
 Table 73. Valneva Sales Proportion of Oral Vaccines by Application in 2024
 Table 74. Valneva Sales Proportion of Oral Vaccines by Geographic Area in 2024
 Table 75. Valneva Recent Developments
 Table 76. Shanghai United Cell Company Information
 Table 77. Shanghai United Cell Description and Business Overview
 Table 78. Shanghai United Cell Oral Vaccines Product
 Table 79. Shanghai United Cell Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. Shanghai United Cell Sales Proportion of Oral Vaccines by Product in 2024
 Table 81. Shanghai United Cell Sales Proportion of Oral Vaccines by Application in 2024
 Table 82. Shanghai United Cell Sales Proportion of Oral Vaccines by Geographic Area in 2024
 Table 83. Shanghai United Cell Recent Developments
 Table 84. Bibcol Company Information
 Table 85. Bibcol Description and Business Overview
 Table 86. Bibcol Oral Vaccines Product
 Table 87. Bibcol Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Bibcol Sales Proportion of Oral Vaccines by Product in 2024
 Table 89. Bibcol Sales Proportion of Oral Vaccines by Application in 2024
 Table 90. Bibcol Sales Proportion of Oral Vaccines by Geographic Area in 2024
 Table 91. Bibcol Recent Developments
 Table 92. PaxVax Company Information
 Table 93. PaxVax Description and Business Overview
 Table 94. PaxVax Oral Vaccines Product
 Table 95. PaxVax Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 96. PaxVax Sales Proportion of Oral Vaccines by Product in 2024
 Table 97. PaxVax Sales Proportion of Oral Vaccines by Application in 2024
 Table 98. PaxVax Sales Proportion of Oral Vaccines by Geographic Area in 2024
 Table 99. PaxVax Recent Developments
 Table 100. Vabiotech Company Information
 Table 101. Vabiotech Description and Business Overview
 Table 102. Vabiotech Oral Vaccines Product
 Table 103. Vabiotech Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 104. Vabiotech Sales Proportion of Oral Vaccines by Product in 2024
 Table 105. Vabiotech Sales Proportion of Oral Vaccines by Application in 2024
 Table 106. Vabiotech Sales Proportion of Oral Vaccines by Geographic Area in 2024
 Table 107. Vabiotech Recent Developments
 Table 108. Tiantan Biological Company Information
 Table 109. Tiantan Biological Description and Business Overview
 Table 110. Tiantan Biological Oral Vaccines Product
 Table 111. Tiantan Biological Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 112. Tiantan Biological Sales Proportion of Oral Vaccines by Product in 2024
 Table 113. Tiantan Biological Sales Proportion of Oral Vaccines by Application in 2024
 Table 114. Tiantan Biological Sales Proportion of Oral Vaccines by Geographic Area in 2024
 Table 115. Tiantan Biological Recent Developments
 Table 116. EuBiologics Company Information
 Table 117. EuBiologics Description and Business Overview
 Table 118. EuBiologics Oral Vaccines Product
 Table 119. EuBiologics Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 120. EuBiologics Sales Proportion of Oral Vaccines by Product in 2024
 Table 121. EuBiologics Sales Proportion of Oral Vaccines by Application in 2024
 Table 122. EuBiologics Sales Proportion of Oral Vaccines by Geographic Area in 2024
 Table 123. EuBiologics Recent Developments
 Table 124. Panacea Biotec Ltd Company Information
 Table 125. Panacea Biotec Ltd Description and Business Overview
 Table 126. Panacea Biotec Ltd Oral Vaccines Product
 Table 127. Panacea Biotec Ltd Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Panacea Biotec Ltd Sales Proportion of Oral Vaccines by Product in 2024
 Table 129. Panacea Biotec Ltd Sales Proportion of Oral Vaccines by Application in 2024
 Table 130. Panacea Biotec Ltd Sales Proportion of Oral Vaccines by Geographic Area in 2024
 Table 131. Panacea Biotec Ltd Recent Developments
 Table 132. Bio-Med Company Information
 Table 133. Bio-Med Description and Business Overview
 Table 134. Bio-Med Oral Vaccines Product
 Table 135. Bio-Med Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 136. Bio-Med Sales Proportion of Oral Vaccines by Product in 2024
 Table 137. Bio-Med Sales Proportion of Oral Vaccines by Application in 2024
 Table 138. Bio-Med Sales Proportion of Oral Vaccines by Geographic Area in 2024
 Table 139. Bio-Med Recent Developments
 Table 140. Halfkin Bio-Pharmaceuticals Company Information
 Table 141. Halfkin Bio-Pharmaceuticals Description and Business Overview
 Table 142. Halfkin Bio-Pharmaceuticals Oral Vaccines Product
 Table 143. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 144. Halfkin Bio-Pharmaceuticals Sales Proportion of Oral Vaccines by Product in 2024
 Table 145. Halfkin Bio-Pharmaceuticals Sales Proportion of Oral Vaccines by Application in 2024
 Table 146. Halfkin Bio-Pharmaceuticals Sales Proportion of Oral Vaccines by Geographic Area in 2024
 Table 147. Halfkin Bio-Pharmaceuticals Recent Developments
 Table 148. North America Oral Vaccines Sales by Country (2020-2025) & (K Units)
 Table 149. North America Oral Vaccines Sales by Country (2026-2031) & (K Units)
 Table 150. North America Oral Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 151. North America Oral Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 152. North America Oral Vaccines Sales by Type (2020-2025) & (K Units)
 Table 153. North America Oral Vaccines Sales by Application (2020-2025) & (K Units)
 Table 154. Asia-Pacific Oral Vaccines Sales by Region (2020-2025) & (K Units)
 Table 155. Asia-Pacific Oral Vaccines Sales by Region (2026-2031) & (K Units)
 Table 156. Asia-Pacific Oral Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 157. Asia-Pacific Oral Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 158. Asia-Pacific Oral Vaccines Sales by Type (2020-2025) & (K Units)
 Table 159. Asia-Pacific Oral Vaccines Sales by Application (2020-2025) & (K Units)
 Table 160. Europe Oral Vaccines Sales by Country (2020-2025) & (K Units)
 Table 161. Europe Oral Vaccines Sales by Country (2026-2031) & (K Units)
 Table 162. Europe Oral Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 163. Europe Oral Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 164. Europe Oral Vaccines Sales by Type (2020-2025) & (K Units)
 Table 165. Europe Oral Vaccines Sales by Application (2020-2025) & (K Units)
 Table 166. Latin America Oral Vaccines Sales by Country (2020-2025) & (K Units)
 Table 167. Latin America Oral Vaccines Sales by Country (2026-2031) & (K Units)
 Table 168. Latin America Oral Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 169. Latin America Oral Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 170. Latin America Oral Vaccines Sales by Type (2020-2025) & (K Units)
 Table 171. Latin America Oral Vaccines Sales by Application (2020-2025) & (K Units)
 Table 172. Middle East and Africa Oral Vaccines Sales by Country (2020-2025) & (K Units)
 Table 173. Middle East and Africa Oral Vaccines Sales by Country (2026-2031) & (K Units)
 Table 174. Middle East and Africa Oral Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 175. Middle East and Africa Oral Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 176. Middle East and Africa Oral Vaccines Sales by Type (2020-2025) & (K Units)
 Table 177. Middle East and Africa Oral Vaccines Sales by Application (2020-2025) & (K Units)
 Table 178. Oral Vaccines Key Raw Materials, Industry Status and Trend
 Table 179. Oral Vaccines Key Raw Materials and Upstream Suppliers
 Table 180. Oral Vaccines Clients Status and Trend
 Table 181. Oral Vaccines Typical Clients
 Table 182. Oral Vaccines Distributors
 Table 183. Oral Vaccines Market Trends
 Table 184. Oral Vaccines Market Drivers
 Table 185. Oral Vaccines Market Challenges
 Table 186. Oral Vaccines Market Restraints
 Table 187. Research Programs/Design for This Report
 Table 188. Key Data Information from Secondary Sources
 Table 189. Key Data Information from Primary Sources
 Table 190. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Oral Vaccines Product Picture
 Figure 2. Global Oral Vaccines Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Oral Vaccines Sales Market Share by Type in 2024 & 2031
 Figure 4. Rotavirus Vaccine Product Picture
 Figure 5. Cholera Vaccine Product Picture
 Figure 6. Oral Polio Vaccine Product Picture
 Figure 7. Global Oral Vaccines Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Oral Vaccines Sales Market Share by Application in 2024 & 2031
 Figure 9. Public
 Figure 10. Private
 Figure 11. Oral Vaccines Report Years Considered
 Figure 12. Global Oral Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Oral Vaccines Market Size 2020-2031 (US$ Million)
 Figure 14. Global Oral Vaccines Sales 2020-2031 (K Units)
 Figure 15. Global Oral Vaccines Sales Market Share Forecast by Region (2020-2031)
 Figure 16. Global Oral Vaccines Revenue Market Share by Region (2020-2031)
 Figure 17. Global Oral Vaccines Sales Market Share Forecast by Type (2020-2031)
 Figure 18. Global Oral Vaccines Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. Oral Vaccines Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 20. Global Oral Vaccines Sales Market Share Forecast by Application (2020-2031)
 Figure 21. Global Oral Vaccines Revenue Market Share Forecast by Application (2020-2031)
 Figure 22. Oral Vaccines Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 23. Rotavirus Vaccine of Oral Vaccines Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Cholera Vaccine of Oral Vaccines Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Oral Polio Vaccine of Oral Vaccines Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Global Oral Vaccines Sales Share by Manufacturer in 2024
 Figure 27. Oral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 28. Rotavirus Vaccine Market Sales Proportion by Manufacturer in 2024
 Figure 29. Cholera Vaccine Market Sales Proportion by Manufacturer in 2024
 Figure 30. Oral Polio Vaccine Market Sales Proportion by Manufacturer in 2024
 Figure 31. North America Oral Vaccines Revenue 2020-2031 (US$ Million)
 Figure 32. North America Oral Vaccines Sales Market Share by Type (2020-2025)
 Figure 33. North America Oral Vaccines Sales Market Share by Application (2020-2025)
 Figure 34. Asia-Pacific Oral Vaccines Revenue 2020-2031 (US$ Million)
 Figure 35. Asia-Pacific Oral Vaccines Sales Market Share by Region (2020-2031)
 Figure 36. Asia-Pacific Oral Vaccines Revenue Market Share by Region (2020-2031)
 Figure 37. Asia-Pacific Oral Vaccines Sales Market Share by Type (2020-2025)
 Figure 38. Asia-Pacific Oral Vaccines Sales Market Share by Application (2020-2025)
 Figure 39. Europe Oral Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 40. Europe Oral Vaccines Sales Market Share by Country (2020-2031)
 Figure 41. Europe Oral Vaccines Revenue Market Share by Country (2020-2031)
 Figure 42. Europe Oral Vaccines Sales Market Share by Type (2020-2025)
 Figure 43. Europe Oral Vaccines Sales Market Share by Application (2020-2025)
 Figure 44. Latin America Oral Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 45. Latin America Oral Vaccines Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Oral Vaccines Revenue Market Share by Country (2020-2025)
 Figure 47. Latin America Oral Vaccines Sales Market Share by Type (2020-2025)
 Figure 48. Latin America Oral Vaccines Sales Market Share by Application (2020-2025)
 Figure 49. Middle East and Africa Oral Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 50. Middle East and Africa Oral Vaccines Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Oral Vaccines Revenue Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Oral Vaccines Sales Market Share by Type (2020-2025)
 Figure 53. Middle East and Africa Oral Vaccines Sales Market Share by Application (2020-2025)
 Figure 54. Oral Vaccines Supply Chain (Upstream and Downstream Market)
 Figure 55. Global Production Market Share of Oral Vaccines Raw Materials by Region in 2024
 Figure 56. Oral Vaccines Distribution Channels
 Figure 57. Global Oral Vaccines Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 58. Global Oral Vaccines Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Vaccines Administered Orally Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Vaccines Administered Orally Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Oral Vaccine Market Research Report 2024
Global Oral Delivery Vaccines Market Research Report 2025
Orally Administered Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Vaccine for Human Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Vaccine Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Vaccination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Rotavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Vaccine Adjuvants Market Research Report 2025
Oral Vaccines Solutions for Pets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Therapeutic Proteins and Oral Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Novel Vaccine Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cholera Vaccines Oral Live Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Live Cholera Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Mucosal Drug Delivery System Market Research Report 2024
Global Oral Drug Delivery Market Research Report 2025
Global Multivalent Oral Rotavirus Vaccine Market Research Report 2024
Oral Vaccines for Aquatic Animals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Insulin Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions